Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study

Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study

Abstract Background Studies have shown that the prognosis of the treatment of methicillin-susceptible S. aureus (MSSA) with glycopeptides is inferior compared to treatment with β-lactam. However, there are only few studies comparing treatment with antistaphylococcal penicillin alone to glycopeptide...

Full description

Bibliographic Details
Main Authors: Dong Hyun Oh, Jung Ju Kim, Jinnam Kim, Hye Seong, Se Ju Lee, Yong Chan Kim, Eun Jin Kim, In Young Jung, Woo Yong Jeong, Su Jin Jeong, Nam Su Ku, Sang Hoon Han, Jun Yong Choi, Young Goo Song, June Myung Kim
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Infectious Diseases
Subjects:
Methicillin-susceptible Staphylococcus aureus
Nafcillin
Antistaphylococcal penicillin
Glycopeptides
Online Access:http://link.springer.com/article/10.1186/s12879-018-2978-z

Internet

http://link.springer.com/article/10.1186/s12879-018-2978-z

Similar Items